...
首页> 外文期刊>U. S. pharmacist >Medication Adherence: The Real Problem When Treating Chronic Conditions
【24h】

Medication Adherence: The Real Problem When Treating Chronic Conditions

机译:药物依从性:治疗慢性病的真正问题

获取原文
获取原文并翻译 | 示例

摘要

Poor adherence to appropriate medication therapy has been shown to result in complications, death, and increased health care costs. Medication adherence in patients with chronic conditions such as diabetes, hypertension, hyper-lipidemia, asthma, and depression is a significant problem requiring intervention. According to the World Health Organization's (WHO) World Health Report 2003, the degree of medication nonadherence is so great and the consequences are of such concern that more people worldwide would benefit from efforts to improve medication adherence than from the development of new medical treatments. In fact, a number of studies have shown that, in developed countries, patients with chronic conditions have adherence rates of 50% to 60%, despite evidence that medication improves quality of life and prevents death. In developing countries, when poor access to health care, possible lack of diagnosis, and limited availability of medications are taken into account, poor adherence threatens all efforts to treat chronic conditions such as diabetes, depression, and HIV/AIDS."
机译:研究表明,对适当药物治疗的依从性差会导致并发症,死亡和医疗费用增加。患有慢性疾病如糖尿病,高血压,高脂血症,哮喘和抑郁症患者的药物依从性是需要干预的重要问题。根据世界卫生组织(WHO)的《 2003年世界卫生报告》,药物不依从的程度如此之大,其后果令人担忧,以至于全世界更多的人将从改善药物依从性的努力中受益,而不是从开发新的药物中受益。实际上,许多研究表明,在发达国家,尽管有证据表明药物可以改善生活质量并防止死亡,但慢性病患者的依从率仍为50%至60%。在发展中国家,当考虑到难以获得保健服务,可能缺乏诊断和药物供应有限时,依从性差会威胁到所有治疗糖尿病,抑郁症和艾滋病毒/艾滋病等慢性病的努力。”

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号